Company: VERA
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029969
Chunk: 2

Company: Vera Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 2
---
 certain cybersecurity incidents to members of management depending on the circumstances, including the Cybersecurity Risk Management Committee. This group works with the Company’s incident response team to help the Company mitigate and remediate cybersecurity incidents of which they are notified. In addition, the Company’s incident response plan includes reporting to the audit committee of the board of directors for certain cybersecurity incidents. The audit committee receives reports concerning the Company’s significant cybersecurity threats and risks and the processes the Company has implemented to address them, including during audit committee meetings and other periodic updates. These reports are provided by members of the Company’s management team responsible for such reporting, including the Cybersecurity Risk 

89

Management Committee. The audit committee also receives various reports, summaries or presentations related to cybersecurity threats, risk and mitigation.